SCHEMBL4688262

SCHEMBL4688262

CCN1C(=S)C(Nc2ccc(OC)cc2)=C(c2ccccc2)C1=S

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 6/20 0.67
NR1H3 Q13133 6/20 0.67
MAPT P10636 9/20 0.47
MEN1 O00255 6/20 0.47
KMT2A Q03164 6/20 0.47
GSK3B P49841 3/20 0.46
SMN1; SMN2 Q16637 4/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
HTT P42858 3/20 0.43
MAPK1 P28482 3/20 0.43
LMNA P02545 2/20 0.43
ALOX12 P18054 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RAB9A P51151 4/20 0.41
KDM4E B2RXH2 3/20 0.41
GAA P10253 3/20 0.41
NPC1 O15118 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TDP1 Q9NUW8 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4684921 0.90 NR1H2 (0.80) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4684894 0.88 NR1H2 (0.56) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4684768 0.88 NR1H2 (0.69) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4685228 0.86 NR1H2 (0.54) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4684728 0.85 NR1H2 (0.53) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4685227 0.83 NR1H2 (0.65) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4684032 0.83 NR1H2 (0.59) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4684751 0.81 NR1H2 (0.66) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4684030 0.81 NR1H2 (0.80) NR1H2NR1H3MAPTMEN1KMT2A
SCHEMBL4685907 0.81 NR1H2 (1.00) NR1H2NR1H3MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1646625-B1 PYRROLE-2, 5-DITHIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2008-07-02 EP claimed
US-20060189663-A1 Pyrrole-2,5-dithione derivatives as liver x receptor modulators ASTRAZENECA AB (SE) 2006-08-24 US claimed
EP-1646625-A1 PYRROLE-2, 5-DITHIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2006-04-19 EP claimed
WO-2005005416-A1 PYRROLE-2, 5-DITHIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2005-01-20 WO claimed
EP-1646625-B1 PYRROLE-2, 5-DITHIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2008-07-02 EP disclosed
US-20060189663-A1 Pyrrole-2,5-dithione derivatives as liver x receptor modulators ASTRAZENECA AB (SE) 2006-08-24 US disclosed
EP-1646625-A1 PYRROLE-2, 5-DITHIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS AstraZeneca AB (SE) 2006-04-19 EP disclosed
WO-2005005416-A1 PYRROLE-2, 5-DITHIONE DERIVATIVES AS LIVER X RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189663-A1 Pyrrole-2,5-dithione derivatives as liver x receptor modulators NR1H2, NR1H3, NR1H4 NR1H2 1/4885NR1H3 2/4885MAPT 2045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.